420 related articles for article (PubMed ID: 17955474)
1. Profiling of vitreous proteomes from proliferative diabetic retinopathy and nondiabetic patients.
Kim T; Kim SJ; Kim K; Kang UB; Lee C; Park KS; Yu HG; Kim Y
Proteomics; 2007 Nov; 7(22):4203-15. PubMed ID: 17955474
[TBL] [Abstract][Full Text] [Related]
2. Differentiating vitreous proteomes in proliferative diabetic retinopathy using high-performance liquid chromatography coupled to tandem mass spectrometry.
Wang H; Feng L; Hu J; Xie C; Wang F
Exp Eye Res; 2013 Mar; 108():110-9. PubMed ID: 23276812
[TBL] [Abstract][Full Text] [Related]
3. Characterization of the vitreous proteome in diabetes without diabetic retinopathy and diabetes with proliferative diabetic retinopathy.
Gao BB; Chen X; Timothy N; Aiello LP; Feener EP
J Proteome Res; 2008 Jun; 7(6):2516-25. PubMed ID: 18433156
[TBL] [Abstract][Full Text] [Related]
4. Periostin, discovered by nano-flow liquid chromatography and mass spectrometry, is a novel marker of diabetic retinopathy.
Takada M; Ban Y; Yamamoto G; Ueda T; Saito Y; Nishimura E; Fujisawa K; Koide R; Mizutani M; Kozawa T; Shiraishi Y; Bando Y; Tachikawa T; Hirano T
Biochem Biophys Res Commun; 2010 Aug; 399(2):221-6. PubMed ID: 20654574
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of vitreous from diabetic macular edema.
Ouchi M; West K; Crabb JW; Kinoshita S; Kamei M
Exp Eye Res; 2005 Aug; 81(2):176-82. PubMed ID: 16080911
[TBL] [Abstract][Full Text] [Related]
6. Identification of phosphotyrosyl proteins in vitreous humours of patients with vitreoretinal diseases by sodium dodecyl sulphate-polyacrylamide gel electrophoresis/Western blotting/matrix-assisted laser desorption time-of-flight mass spectrometry.
Mukai N; Nakanishi T; Shimizu A; Takubo T; Ikeda T
Ann Clin Biochem; 2008 May; 45(Pt 3):307-12. PubMed ID: 18482920
[TBL] [Abstract][Full Text] [Related]
7. [New exploration of treatment target for proliferative diabetic retinopathy based on iTRAQ LC-MS/MS Proteomics].
Wen DJ; Ren XJ; Dong LJ; He Y; Li XR
Zhonghua Yan Ke Za Zhi; 2019 Oct; 55(10):769-776. PubMed ID: 31607066
[No Abstract] [Full Text] [Related]
8. Chemokines in proliferative diabetic retinopathy and proliferative vitreoretinopathy.
Abu El-Asrar AM; Struyf S; Kangave D; Geboes K; Van Damme J
Eur Cytokine Netw; 2006 Sep; 17(3):155-65. PubMed ID: 17194635
[TBL] [Abstract][Full Text] [Related]
9. Atrial natriuretic peptide in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Rollin R; Mediero A; Martínez-Montero JC; Roldán-Pallarés M; Suárez-Leoz M; Vidal-Fernández P; Cortés-Valdés C; Fernández-Cruz A; Fernández-Durango R
Mol Vis; 2004 Jul; 10():450-7. PubMed ID: 15273657
[TBL] [Abstract][Full Text] [Related]
10. Immunoreactive endothelin-1 in the vitreous humor and epiretinal membranes of patients with proliferative diabetic retinopathy.
Roldán-Pallarés M; Rollín R; Martínez-Montero JC; Fernández-Cruz A; Bravo-Llata C; Fernández-Durango R
Retina; 2007 Feb; 27(2):222-35. PubMed ID: 17290206
[TBL] [Abstract][Full Text] [Related]
11. Positive association of pigment epithelium-derived factor with total antioxidant capacity in the vitreous fluid of patients with proliferative diabetic retinopathy.
Yokoi M; Yamagishi S; Saito A; Yoshida Y; Matsui T; Saito W; Hirose S; Ohgami K; Kase M; Ohno S
Br J Ophthalmol; 2007 Jul; 91(7):885-7. PubMed ID: 17301120
[TBL] [Abstract][Full Text] [Related]
12. Biomarker discovery for kidney diseases by mass spectrometry.
Niwa T
J Chromatogr B Analyt Technol Biomed Life Sci; 2008 Jul; 870(2):148-53. PubMed ID: 18024247
[TBL] [Abstract][Full Text] [Related]
13. Vitreous proteomic analysis of proliferative vitreoretinopathy.
Yu J; Liu F; Cui SJ; Liu Y; Song ZY; Cao H; Chen FE; Wang WJ; Sun T; Wang F
Proteomics; 2008 Sep; 8(17):3667-78. PubMed ID: 18752205
[TBL] [Abstract][Full Text] [Related]
14. Differential expression of vitreous proteins in proliferative diabetic retinopathy.
Kim SJ; Kim S; Park J; Lee HK; Park KS; Yu HG; Kim Y
Curr Eye Res; 2006 Mar; 31(3):231-40. PubMed ID: 16531280
[TBL] [Abstract][Full Text] [Related]
15. Identification of an anti-aldolase autoantibody as a diagnostic marker for diabetic retinopathy by immunoproteomic analysis.
Ahn BY; Song ES; Cho YJ; Kwon OW; Kim JK; Lee NG
Proteomics; 2006 Feb; 6(4):1200-9. PubMed ID: 16421937
[TBL] [Abstract][Full Text] [Related]
16. Effect of retinal laser photocoagulation on the activity of metalloproteinases and the alpha(2)-macroglobulin proteolytic state in the vitreous of eyes with proliferative diabetic retinopathy.
Sánchez MC; Luna JD; Barcelona PF; Gramajo AL; Juarez PC; Riera CM; Chiabrando GA
Exp Eye Res; 2007 Nov; 85(5):644-50. PubMed ID: 17826767
[TBL] [Abstract][Full Text] [Related]
17. Metabolic fingerprints of proliferative diabetic retinopathy: an 1H-NMR-based metabonomic approach using vitreous humor.
Barba I; Garcia-Ramírez M; Hernández C; Alonso MA; Masmiquel L; García-Dorado D; Simó R
Invest Ophthalmol Vis Sci; 2010 Sep; 51(9):4416-21. PubMed ID: 20375324
[TBL] [Abstract][Full Text] [Related]
18. Identification and localization of major soluble vitreous proteins in human ocular tissue.
Wu CW; Sauter JL; Johnson PK; Chen CD; Olsen TW
Am J Ophthalmol; 2004 Apr; 137(4):655-61. PubMed ID: 15059704
[TBL] [Abstract][Full Text] [Related]
19. Vitreous levels of interleukin-8 in patients with proliferative diabetic retinopathy.
Petrovic MG; Korosec P; Kosnik M; Hawlina M
Am J Ophthalmol; 2007 Jan; 143(1):175-6. PubMed ID: 17188064
[TBL] [Abstract][Full Text] [Related]
20. Proteomics and diabetic retinopathy.
Merchant ML; Klein JB
Clin Lab Med; 2009 Mar; 29(1):139-49. PubMed ID: 19389556
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
